Von Willebrand's disease in gynecologic practice

Obstetrics and Gynecology

Volumn 98, Issue 6, 2001, Pages 1185-1186

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN ACETATE; ORAL CONTRACEPTIVE AGENT; VON WILLEBRAND FACTOR;

BLEEDING DISORDER; BLOOD CLOTTING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HEMOSTASIS; HUMAN; HYSTERECTOMY; MEDICAL PRACTICE; MENORRHAGIA; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; TREATMENT INDICATION; UTERUS BLEEDING; VON WILLEBRAND DISEASE; ARTICLE; FEMALE; GYNECOLOGY; PRACTICE GUIDELINE;

FEMALE; GYNECOLOGY; HUMAN; PRACTICE GUIDELINES; VON WILLEBRAND DISEASE;

EID: 0035693581     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01706-9     Document Type: Short Survey

References (14)

1. Epidemiological investigation of the prevalence of von Willebrand's disease
2. Prevalence of von Willebrand disease in children: A multiethnic study
3. Differential diagnosis of abnormal uterine bleeding
4. The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding
5. Acute adolescent menorrhagia
6. On the value of menorrhagia as a predictor for coagulation disorders
7. Frequency of inherited bleeding disorders in women with menorrhagia
8. Management of abnormal uterine bleeding
9. Von Willebrand disease: Recent advances in pathophysiology and treatment
10. Relative value of diagnostic studies for von Willebrand disease
11. Screening and diagnosis of coagulation disorders
12. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: Results of an international survey. On behalf of the subcommittee on von Willebrand factor of the scientific and standardization committee of the ISTH
13. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: Effect on bleeding symptoms and socioeconomic factors